CLOs on the Move


 
Dexter is a prominent North American manufacturer of trailer components, with over 60 years of experience in the industry. Since becoming part of DexKo Global in 2015, Dexter has combined its expertise with AL-KO Vehicle Technology to enhance its offerings. The company operates manufacturing facilities across the U.S. and Canada, serving various markets including utility trailers, recreational vehicles (RVs), marine, heavy-duty, agricultural, and specialty equipment. Dexters product range includes trailer axles and brakes, featuring hydraulic disc and electric brakes, as well as advanced safety systems. The company also offers specialized components such as bearing protection systems and corrosion-resistant parts. With a ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $500M-1 Billion

Executives

Name Title Contact Details

Similar Companies

Ampersand

Ampersand is a multiscreen advanced TV advertising company that helps brands reach their audiences with precision at scale. The company specializes in providing advanced advertising solutions across various screens, including television and digital platforms. Ampersand offers services that enhance audience targeting through data and analytics, enabling brands to identify and connect with specific audience segments. They manage ad campaigns across multiple screens, such as TV, mobile, and desktop, ensuring efficient ad delivery to maximize brand impact. Their focus on ad optimization helps brands achieve their advertising goals effectively.

Invest HR

Invest HR is a Aurora, IL-based company in the Business Services sector.

Astarte Cosmetics Inc

Astarte Cosmetics Inc is a New York, NY-based company in the Business Services sector.

OpenCell Technologies, Inc.

OpenCell Technologies provides efficient, high-throughput and scalable transfection tools to researchers in the Life Sciences, enabling them to use difficult-to-transfect cells (e.g., primary and cancer stem cell cultures) in development of cell-based analysis techniques and discovery of new cancer therapies. Unlike currently available products, the OpenCell technology features precise control of biophysical actions on a single-cell basis without sacrificing throughput. OpenCells vision is to realize a novel, cost-effective approach to transfection that overcome existing research and development obstacles.